As part of the arrangements for the Placing, three Non-executive Directors subscribed for approximately £225,000 in the Placing, representing 9% of the issue. These Directors' beneficial interests are now as follows:
Name of Director Number of New Ordinary Shares subscribed as part of Placing Holding of shares following issue of New Ordinary Shares % of enlarged issued share capital
Nigel Keen 789,000 6,687,547 4.1
Sir Duncan Nichol 131,500 853,916 0.5
Julian Cazalet 263,000 3,880,882 2.4
The Company has 164,190,150 ordinary shares in issue. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in Deltex Medical Group plc, under the Disclosure and Transparency Rules.
For further information, please contact:-
Nigel Keen, Chairman
Ewan Phillips, Chief Executive
Paul Mitchell, Finance Director
Christopher Hardie
distributed by
|